Dragan Micic

Summary

Publications

  1. ncbi Metformin: its emerging role in oncology
    Dragan Micic
    Institute of Endocrinology, Diabetes and Diseases of Metabolism, University of Belgrade, Serbia
    Hormones (Athens) 10:5-15. 2011
  2. doi Intracerebroventricular administration of metformin inhibits ghrelin-induced Hypothalamic AMP-kinase signalling and food intake
    Darko Stevanovic
    Institute of Medical Physiology, University of Belgrade, Belgrade, Serbia
    Neuroendocrinology 96:24-31. 2012
  3. doi Inhibition of AMPK-dependent autophagy enhances in vitro antiglioma effect of simvastatin
    Maja Misirkic
    Institute of Microbiology and Immunology, School of Medicine, University of Belgrade, Dr Subotica 1, 11000 Belgrade, Serbia
    Pharmacol Res 65:111-9. 2012
  4. doi Therapeutic improvement of glucoregulation in newly diagnosed type 2 diabetes patients is associated with a reduction of IL-17 levels
    Mirjana Sumarac-Dumanovic
    Clinic for Endocrinology, Diabetes and Diseases of Metabolism, School of Medicine, University of Belgrade, Dr Subotica 13, Belgrade 11000, Serbia
    Immunobiology 218:1113-8. 2013
  5. doi Immunomodulatory actions of central ghrelin in diet-induced energy imbalance
    Darko Stevanovic
    Institute of Medical Physiology, School of Medicine, University of Belgrade, 11000 Belgrade, Serbia
    Brain Behav Immun 26:150-8. 2012
  6. doi In vitro and in vivo anti-melanoma action of metformin
    Kristina Janjetovic
    Institute of Microbiology and Immunology, School of Medicine, University of Belgrade, Dr Subotica 1, 11000 Belgrade, Serbia
    Eur J Pharmacol 668:373-82. 2011

Collaborators

  • Mirjana Sumarac-Dumanovic
  • Darko Stevanovic
  • Kristina Janjetovic
  • Vladimir Trajkovic
  • Maja Misirkic
  • Ljubica Vucicevic
  • Vesna Starcevic
  • Urosh Vilimanovich
  • Ljubica Harhaji-Trajkovic
  • Aleksandar Pantovic
  • Danka Jeremić
  • Goran Cvijovic
  • Danica Stamenkovic-Pejkovic
  • Emina Sudar
  • Emina Savic
  • Dejan Nesić
  • Vladimir Bumbasirevic
  • Gordana Tovilovic
  • Biljana Ristic
  • Dusan Popadic
  • Maja Misirkic-Marjanovic
  • Nevena Zogovic

Detail Information

Publications6

  1. ncbi Metformin: its emerging role in oncology
    Dragan Micic
    Institute of Endocrinology, Diabetes and Diseases of Metabolism, University of Belgrade, Serbia
    Hormones (Athens) 10:5-15. 2011
    ..These new encouraging experimental data supporting the anti-cancer effects of metformin urgently require further clinical studies in order to establish its use as a synergistic therapy targeting the AMPK/mTOR signaling pathway...
  2. doi Intracerebroventricular administration of metformin inhibits ghrelin-induced Hypothalamic AMP-kinase signalling and food intake
    Darko Stevanovic
    Institute of Medical Physiology, University of Belgrade, Belgrade, Serbia
    Neuroendocrinology 96:24-31. 2012
    ..The present study investigated the effects of intracerebroventricular administration of metformin on food intake and hypothalamic appetite-regulating signalling pathways induced by the orexigenic peptide ghrelin...
  3. doi Inhibition of AMPK-dependent autophagy enhances in vitro antiglioma effect of simvastatin
    Maja Misirkic
    Institute of Microbiology and Immunology, School of Medicine, University of Belgrade, Dr Subotica 1, 11000 Belgrade, Serbia
    Pharmacol Res 65:111-9. 2012
    ..These data suggest that inhibition of AMPK-dependent autophagic response might sensitize glioma cells to statin-induced apoptotic death...
  4. doi Therapeutic improvement of glucoregulation in newly diagnosed type 2 diabetes patients is associated with a reduction of IL-17 levels
    Mirjana Sumarac-Dumanovic
    Clinic for Endocrinology, Diabetes and Diseases of Metabolism, School of Medicine, University of Belgrade, Dr Subotica 13, Belgrade 11000, Serbia
    Immunobiology 218:1113-8. 2013
    ..2 to 12.9 pg/ml, p=0.020), but not IFN-γ (50.6 vs. 52.3, p=0.349). These data indicate that therapeutic improvement of glucoregulation might contribute to a reduction of IL-17 levels in newly diagnosed type 2 diabetes patients...
  5. doi Immunomodulatory actions of central ghrelin in diet-induced energy imbalance
    Darko Stevanovic
    Institute of Medical Physiology, School of Medicine, University of Belgrade, 11000 Belgrade, Serbia
    Brain Behav Immun 26:150-8. 2012
    ..Therefore, central ghrelin may play a complex role in energy imbalance-induced inflammation by modulating HPA axis, leptin and AMPK/ERK signaling pathways...
  6. doi In vitro and in vivo anti-melanoma action of metformin
    Kristina Janjetovic
    Institute of Microbiology and Immunology, School of Medicine, University of Belgrade, Dr Subotica 1, 11000 Belgrade, Serbia
    Eur J Pharmacol 668:373-82. 2011
    ..These data suggest that anti-melanoma effects of metformin are mediated through p21- and AMPK-independent cell cycle arrest, apoptosis and autophagy associated with p53/Bcl-2 modulation, mitochondrial damage and oxidative stress...